USFDA completes inspection of Lupin’s Nagpur plant

New Delhi: Pharma major Lupin today said the US health regulator has completed inspection of its Nagpur facility without making any observations.

In a BSE filing, Lupin “announced successful completion of an inspection carried out by the United States Food and Drug Administration (USFDA) at its Nagpur facility. The inspection concluded without any observations”.

Lupin said its Nagpur facility manufactures oral solid products.

Shares of Lupin were trading 2.09 per cent higher at Rs 767.50 on BSE.

  • Related Posts

    Government takes steps to strengthen primary healthcare services

    The Union minister of state for health and family welfare, Prataprao Jadhav stated that the government has taken steps to strengthen primary healthcare services in the country. The ministry of…

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    NEW DELHI: In a major victory for India’s national security and anti-narcotics apparatus, the Central Bureau of Narcotics (CBN), operating under the Department of Revenue, Ministry of Finance, has dismantled…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Government takes steps to strengthen primary healthcare services

    Government takes steps to strengthen primary healthcare services

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

    Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

    Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

    Chemists demand fair competition in pharma market amid online sales concerns

    Chemists demand fair competition in pharma market amid online sales concerns

    DCA busts unlicensed shop, seizes meds worth Rs 18000

    DCA busts unlicensed shop, seizes meds worth Rs 18000